Drug targets for Cancer: HSP90

Drug Targets for Cancer: HSP90 and Cancer

Heat-shock proteins (HSPs) are molecular chaperones that regulate protein folding to ensure correct conformation and translocation and to avoid protein aggregation. Heat-shock proteins are increased in many solid tumours and haematological malignancies. Many oncogenic proteins responsible for the transformation of cells to cancerous forms are client proteins of HSP90, such as Prosurvival signalling molecules, Steroid hormone receptors,Steroid hormone receptors, Angiogeneic mediators, Apoptotic mediators Tumour suppressor genes,Cell cycle regulatory proteins and Mediators of tissue invasion and metastasis. Targeting HSP90 with chemical inhibitors would degrade these oncogenic proteins, and thus serve as useful anticancer agents.

Drug Targets for Cancer: HSP90 related Products

Drug targets for cancer: HSP90 research reagents

Other vital drug targets for cancer likeHSP90:

Drug Targets for Cancer: HSP90 Related Reference

Mahalingam D, Swords R, Carew JS, Nawrocki ST, Bhalla K, Giles FJ. Targeting HSP90 for cancer therapy. British Journal of Cancer. 2009;100(10):1523-1529.

Drug Targets for Cancer: HSP90 Related Information

Drug Targets for Cancer